Udai P. Singh, Ph.D.
Assistant Professor of Pathology, Microbiology and Immunology
Assistant Director, Flow Cytometry Facility
University of South Carolina School of Medicine
Columbia, South Carolina, USA
Dr. Udai Singh is in academia since 22 years. Presently Dr. Singh serving as Assistant Director for Sterile Cell Sorting Core facilities at University of South Carolina School of Medicine,Columbia USA. Dr. Singh past training and research work have been mostly related to cellular and mucosal immunology, especially on inflammatory bowel disease (IBD) and inflammation.
Dr. Singh have published over 60 peer-reviewed papers most of them in the area of inflammation as it relates to, autoimmune disease, intestinal inflammation and immune responses. Dr. Singh demonstrated for the first time that anti-CXCL10 (chemokine) Ab treatment abrogated colitis in IL-10-/- mice. Dr. Singh have extensive experience in studying the immune response and alsodemonstrate that polyphenols such as resveratrol can enhance SIRT-1 expression in the lamin propria lymphocytes and down regulate NF-kB activation, leading to decreased inflammation in the colon.
Dr. Singh presently investigating the mechanisms underlying the effects of CAM compounds on inflammation and IBD. Dr. Singh research work has resulted in several invited lectures, multiple publications and a patent. Due to expertise in immunology, gaining knowledge in area of CAM compounds, Dr. Singh works as principal investigator in many research proposals. Dr. Singh is directing the cell-processing unit of GIOSTAR.